V
MANE
VERADERMICS INC
108.96
-9.91-8.34%After Hours: 109.00 +0.04 +0.04%16:57 10/06 EDT
OPEN/PREV CLOSE119.29/118.87
TODAY RANGE108.77-119.29
VOL735.32K
MARKET CAP4.55B
52 WEEK RANGE32.00-131.24
AVG VOL (3M)720.37K
% TURNOVER1.76%
TURNOVER--
P/E (TTM)-32.5205
% RANGE8.59%
EPS(TTM)-3.3505
P/E(FORWARD)-38.0713
P/B5.60
BVPS19.47
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.20B
SHARES OUTSTANDING41.78M
NEXT EARNINGS--
FREE FLOAT38.53M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·09/22 14:44
Novo eyes hair-loss market as Ozempic maker looks to diversify
Seeking Alpha·09/18 13:39
Veradermics: Buy Before The Catalysts
Seeking Alpha·09/15 10:30
HQL: The Rally That Makes Growth Harder (Rating Downgrade)
TipRanks·09/15 10:10
Citi opens ‘upside 90-day catalyst watch’ on Veradermics into data
TipRanks·09/10 10:16
Citi Keeps Their Buy Rating on Veradermics, Incorporated (MANE)
TipRanks·09/08 13:05
Jefferies Remains a Buy on Veradermics, Incorporated (MANE)
Seeking Alpha·08/27 23:09
THQ Offers High-Yield Income From Healthcare Stocks (Rating Upgrade)
Simply Wall St·08/16 13:06
This Insider Has Just Sold Shares In Veradermics
Simply Wall St·08/14 11:24
We Think Veradermics (NYSE:MANE) Can Afford To Drive Business Growth
TipRanks·08/13 16:05
Citi Sticks to Its Buy Rating for Veradermics, Incorporated (MANE)
Benzinga·08/11 20:54
Veradermics Q2 EPS $(0.58) Beats $(0.65) Estimate
TipRanks·08/11 11:42
Veradermics sees cash runway into 2030
Same Industry
Name/Symbol
Change%
Price